Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial
2008

Clomifene Citrate vs. Intrauterine Insemination for Unexplained Infertility

Sample size: 580 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bhattacharya S, Harrild K, Mollison J, Wordsworth S, Tay C, Harrold A, McQueen D, Lyall H, Johnston L, Burrage J, Grossett S, Walton H, Lynch J, Johnstone A, Kini S, Raja A, Templeton A

Primary Institution: Department of Obstetrics and Gynaecology, University of Aberdeen

Hypothesis

Is clomifene citrate or unstimulated intrauterine insemination more effective than expectant management for unexplained infertility?

Conclusion

Clomifene citrate and unstimulated intrauterine insemination do not significantly improve live birth rates compared to expectant management in couples with unexplained infertility.

Supporting Evidence

  • Live birth rates were 17% for expectant management, 14% for clomifene citrate, and 23% for intrauterine insemination.
  • Women found clomifene citrate and intrauterine insemination more acceptable than expectant management.
  • The study included 580 couples, exceeding the recruitment target with less than 1% loss to follow-up.

Takeaway

This study looked at whether two common treatments for infertility help couples have babies better than just waiting. It found that the treatments didn't really work better than doing nothing.

Methodology

A three-arm parallel group, pragmatic randomised controlled trial conducted in four teaching hospitals and one district general hospital in Scotland.

Potential Biases

The presence of mild male factor infertility and minimal endometriosis may introduce clinical heterogeneity.

Limitations

The trial may not be generalizable to other populations and did not address the combined approach of clomifene citrate and intrauterine insemination.

Participant Demographics

Couples with over two years of infertility, confirmed ovulation, patent fallopian tubes, and motile sperm.

Statistical Information

P-Value

0.001

Confidence Interval

0.45 to 1.38 for clomifene citrate; 0.88 to 2.43 for intrauterine insemination

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1136/bmj.a716

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication